New substituted benzimidazole derivatives: a patent review (2010 - 2012)
- PMID: 23675911
- DOI: 10.1517/13543776.2013.800857
New substituted benzimidazole derivatives: a patent review (2010 - 2012)
Abstract
Introduction: Benzimidazole is a heterocyclic aromatic system, which is part of some natural and many synthetic compounds. A large number of benzimidazoles and its derivatives are found to be biologically active against many diseases. Researchers around the world are paying greater attention to and showing increasing interests in this field.
Areas covered: Areas covered in this paper include a review of the synthesis, biological effects and mechanisms of benzimidazole derivatives in the past 2 years, based on literature and patents. The patent databases SciFinder and esp@cenet were used to locate patent applications that were published between 2010 to present. Information from articles published is also included. The current state and problems are also discussed.
Expert opinion: Benzimidazole derivatives possess a broad spectrum of biological activities, whose scopes of treatment ranging from ordinary antimicrobial activities to world's most deadly diseases. However, challenges such as drug resistance, relatively little knowledge of structure of receptors and rare convenient methods for synthesis of benzimidazoles still exist.
Similar articles
-
New substituted benzimidazole derivatives: a patent review (2013 - 2014).Expert Opin Ther Pat. 2015 May;25(5):595-612. doi: 10.1517/13543776.2015.1015987. Expert Opin Ther Pat. 2015. PMID: 25887338 Review.
-
Pyrazine derivatives: a patent review (2008 - present).Expert Opin Ther Pat. 2012 Sep;22(9):1033-51. doi: 10.1517/13543776.2012.714370. Epub 2012 Aug 6. Expert Opin Ther Pat. 2012. PMID: 22860922 Review.
-
Synthesis, in-vitro microbial and cytotoxic studies of new benzimidazole derivatives.Arch Pharm (Weinheim). 2009 Jul;342(7):412-9. doi: 10.1002/ardp.200900022. Arch Pharm (Weinheim). 2009. PMID: 19517452
-
Synthesis, characterization and antimicrobial studies of some new quinoline incorporated benzimidazole derivatives.Eur J Med Chem. 2012 Aug;54:900-6. doi: 10.1016/j.ejmech.2012.05.027. Epub 2012 Jun 1. Eur J Med Chem. 2012. PMID: 22732060
-
Synthesis and QSAR evaluation of 2-(substituted phenyl)-1H-benzimidazoles and [2-(substituted phenyl)-benzimidazol-1-yl]-pyridin-3-yl-methanones.Eur J Med Chem. 2009 Mar;44(3):1119-27. doi: 10.1016/j.ejmech.2008.06.009. Epub 2008 Jun 24. Eur J Med Chem. 2009. PMID: 18657885
Cited by
-
Hybrids of Benzimidazole-oxadiazole: A New Avenue for Synthesis, Pharmacological Activity and Recent Patents for the Development of More Effective Ligands.Curr Org Synth. 2024;21(8):976-1013. doi: 10.2174/0115701794260740231010111408. Curr Org Synth. 2024. PMID: 37916627 Review.
-
An Outline on Benzimidazole Containing Marketed Drugs with Proton Pump Inhibitor and H1 Receptor Antagonist Activities.Mini Rev Med Chem. 2025;25(6):440-462. doi: 10.2174/0113895575329633240928163509. Mini Rev Med Chem. 2025. PMID: 39779557 Review.
-
New Benzimidazole 3'-Deoxynucleosides: Synthesis and Antiherpes Virus Properties.Biomolecules. 2025 Jun 23;15(7):922. doi: 10.3390/biom15070922. Biomolecules. 2025. PMID: 40723794 Free PMC article.
-
Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach.Chem Zvesti. 2022;76(2):1107-1117. doi: 10.1007/s11696-021-01900-8. Epub 2021 Oct 18. Chem Zvesti. 2022. PMID: 34690413 Free PMC article.
-
A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives.Front Pharmacol. 2021 Nov 3;12:762807. doi: 10.3389/fphar.2021.762807. eCollection 2021. Front Pharmacol. 2021. PMID: 34803707 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous